On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been “resolved”. The tirzepatide injection had appeared...more
In the effort to enhance product quality and the integrity of the infant formula supply chain after contamination resulted in the 2022 baby formula shortage, Congress and the FDA took steps to ensure that infants and parents...more
The fashion industry has experienced another year of continued change driven by consumer trends, innovation in technology, geopolitical and public health issues, and legal developments, and we don’t anticipate that stopping...more
4/18/2023
/ Blockchain ,
Class Action ,
Copyright Infringement ,
Fashion Industry ,
Jack Daniels Properties Inc v VIP Products LLC ,
Lanham Act ,
Louis Vuitton ,
Mexico ,
Non-Fungible Tokens (NFTs) ,
Petition for Writ of Certiorari ,
PFAS ,
SCOTUS ,
Supply Chain ,
Trademarks
On August 6, 2020, President Trump signed an Executive Order (“Order”) to ensure essential medicines, medical countermeasures, and critical inputs are made in the United States. The President recognized that reliable...more
9/10/2020
/ Administrative Procedure Act ,
APIs ,
Department of Health and Human Services (HHS) ,
Essential Drug List ,
Executive Orders ,
Food and Drug Administration (FDA) ,
Medical Devices ,
Personal Protective Equipment ,
Prescription Drugs ,
Public Health Emergency ,
Stafford Act ,
Supply Chain ,
Trade Agreements